Product Image

True Focus

NOW
4.5
★ ★ ★ ★ ★
(358 ratings)
Tyrosine 800 mg
Phenylalanine 300 mg
Deanol 60 mg
Coenzyme Q-10 10 mg
Ginkgo
Product Image
Score74
A well-valued focus formula led by tyrosine, phenylalanine, and standardized ginkgo, with several underpowered extras.
How scoring works
Quantity:90 Capsule(s) • (45 servings)
Goals:
Brain Health

Score 74

A well-valued focus formula led by tyrosine, phenylalanine, and standardized ginkgo, with several underpowered extras.
How scoring works
$12.70($0.28 per serving)
Vitacost
$ 14.63
Daily Vita
$ 12.70
Report prices

Analysis

Tyrosine and phenylalanine provide substantial amino-acid support for catecholamine production, which may help focus during demanding periods. Vitamin B6 supports related metabolism at a clearly disclosed amount.

Ginkgo is identified by active markers, while grape-seed polyphenols add antioxidant support. DMAE, taurine, and ubiquinone CoQ10 are present at modest amounts that are unlikely to drive the formula alone.

The two-capsule serving offers favorable value for a multi-ingredient focus product. No strong vision-specific ingredient is included, so that goal is secondary.

Who is it for
  • Adults seeking non-caffeine focus support
  • Users facing mentally demanding work
  • People who tolerate amino-acid-based formulas
Best for
  • Mental focus
  • Task productivity
  • Cognitive support during stress

Pros

  • Substantial tyrosine amount
  • Includes standardized ginkgo
  • Favorable serving value

Cons

  • CoQ10 and taurine are lightly dosed
  • Weak fit for vision support
  • Several ingredients add complexity without strong dose depth

Warnings

  • Phenylalanine is unsuitable for people with phenylketonuria
  • Ginkgo may increase bleeding tendency with anticoagulant or antiplatelet medicines
  • Tyrosine can interact with MAO inhibitors and thyroid medication

Nutrient quality

79 High impact

A strong tyrosine dose anchors a coherent focus formula. Several secondary ingredients are modest, and phenylalanine creates a specific suitability limit.

.

Ingredient transparency

73 High impact

Most active names and total amounts are visible. Repeated source entries and missing non-active ingredients reduce clarity.

.

Customer satisfaction

60 Moderate impact

The supplied average rating is mixed. No specific review comments were supplied, so repeated negative experiences cannot be assessed.

.

Value for money

85 Highest impact

The strong tyrosine dose provides good practical value. Lower secondary doses are a modest trade-off rather than a major cost problem.

.
Report analysis

Goals

Brain Health
Brain Health
Impact
Highest effect
B+ Goal FitB- Strength of SupportB CoverageA- Formula Quality
Vitamin B6 · 12 mg

An effective L-tyrosine amount, phenylalanine, DMAE, and ginkgo create a focused plan for catecholamine and cholinergic support. Tyrosine has the strongest dose and evidence within the formula.

Ginkgo is below a typical clinical amount and lacks verified marker percentages, while DMAE evidence is less established. Ginkgo can increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Phenylalanine Adverse 77 studies
Tyrosine Supportive 7 studies

Ingredients

IngredientAmount per serving
Vitamin C (Potassium Ascorbate)
 36 mg
Vitamin B6 (Pyridoxine Hydrochloride)
 12 mg
Potassium (Potassium Ascorbate)
 10 mg
L-Tyrosine
800 mg
L-Phenylalanine
300 mg
Taurine
100 mg
Grape seed extract (Polyphenols)
 80 mg
Potassium Ascorbate powder
60 mg
DMAE (Dimethylaminoethanol Bitartrate)
 60 mg
Ginkgo extract (Ginkgoflavonglycosides, Terpene Lactones)
 40 mg
CoQ10 (Ubiquinone)
 10 mg
Gluten Free Adults 18–50 Kosher Dairy Free
Report overview
Tyrosine · 800 mg OverallScore84
B- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyB+ Value

The 800 mg L-Tyrosine dose sits in the effective range for acute cognitive support. The amount is clearly disclosed, but no ingredient-specific purity or sourcing evidence is provided. Cost efficiency is favorable compared with most multi-ingredient formulas in the set.

View ingredientView products
Phenylalanine · 300 mg OverallScore77
A+ Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyB- Value

The clearly identified L-form and targeted nootropic format fit brain-focused use better than a complete amino acid blend. A 300 mg serving is a moderate amount, though it falls below the rubric's full-dose threshold. Cost efficiency is reasonable, but the provided label details do not show a PKU warning.

View ingredientView products
Deanol (Dimethylaminoethanol Bitartrate) · 60 mg OverallScore58
B- Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyC Value
The label clearly identifies DMAE bitartrate, but it gives only the salt weight rather than active Deanol yield. After conversion from the salt weight, the active amount is very low. No Deanol-specific safety warning is included, while the two-capsule serving is practical and the broad stack supports neutral Deanol value.
View ingredientView products
Loading alternative details
75 Performance

Dopamine Brain Food

NS Natural Stacks
<p>Active B-vitamin forms plus tyrosine and phenylalanine create a more concentrated amino-acid and cofactor approach to focus. It improves nutrient quality and disclosure, though it does not provide the original product's ginkgo or CoQ10.</p>
75 Performance

Brain Cell Support

Metabolic Maintenance
<p>Citicoline, phosphatidylserine, acetyl-L-carnitine, DMAE, and standardized ginkgo provide broader direct support for focus and brain health. The ginkgo and DMAE doses are more substantial than in the original, while the formula avoids phenylalanine.</p>
73 Performance

Neuro-Peak

ZHOU
<p>Bacopa, ginkgo, rhodiola, methylcobalamin, and DMAE form a focused cognitive blend with stronger value and productivity evidence than the original. Huperzia is also listed, so people sensitive to cholinergic ingredients should review suitability carefully.</p>
61 Budget

Brain Essentials

Swanson
<p>The overlap with tyrosine, ginkgo, and DMAE keeps the comparison relevant while the lower serving cost makes it the only clearly cheaper eligible option. Its key ingredients are generally dosed below those in the original, so the savings come with a meaningful potency trade-off.</p>
61 Value

Brain Essentials

Swanson
<p>The overlap with tyrosine, ginkgo, and DMAE keeps the comparison relevant while the lower serving cost makes it the only clearly cheaper eligible option. Its key ingredients are generally dosed below those in the original, so the savings come with a meaningful potency trade-off.</p>
73 Value

Neuro-Peak

ZHOU
<p>Bacopa, ginkgo, rhodiola, methylcobalamin, and DMAE form a focused cognitive blend with stronger value and productivity evidence than the original. Huperzia is also listed, so people sensitive to cholinergic ingredients should review suitability carefully.</p>
72 Value

NeuroIGNITE

Havasu Nutrition
<p>Bacopa, phosphatidylserine, ginkgo, DMAE, and acetyl-L-carnitine offer a broader cognitive blend with solid value indicators. St. John's wort creates important medicine-interaction concerns, so this option needs a careful suitability check.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  2. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health forGinkgo
  3. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands--A review.
    Jongkees BJ; Hommel B; Kühn S; Colzato LS · Journal of psychiatric research · 2016
    Narrative reviewBrain Health forTyrosine
  4. Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating.
    Jongkees BJ · Cognitive, affective & behavioral neuroscience · 2021
    Randomized trial45 participantsBrain Health forTyrosine
  5. Transient brain structure changes after high phenylalanine exposure in adults with phenylketonuria.
    Muri R; Rummel C; McKinley R; Rebsamen M; Maissen-Abgottspon S; Kreis R; Radojewski P; Pospieszny K; Hochuli M; Wiest R; Trepp R; Everts R · Brain : a journal of neurology · 2024
    Randomized trial28 participantsBrain Health forPhenylalanine
  6. The complete European guidelines on phenylketonuria: diagnosis and treatment.
    van Wegberg AMJ; MacDonald A; Ahring K; Bélanger-Quintana A; Blau N; Bosch AM; Burlina A; Campistol J; Feillet F; Giżewska M; Huijbregts SC; Kearney S; Leuzzi V; Maillot F; Muntau AC; van Rijn M; Trefz F; Walter JH; van Spronsen FJ · Orphanet journal of rare diseases · 2018
    Guideline / consensusBrain Health forPhenylalanine
  7. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health forGinkgo
  8. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health forGinkgo
  9. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health forGinkgo
  10. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  11. The Association between Dietary Amino Acid Intake and Cognitive Decline 8 Years Later in Japanese Community-Dwelling Older Adults.
    Kinoshita K; Otsuka R; Takada M; Tsukamoto-Yasui M; Nishita Y; Tange C; Tomida M; Shimokata H; Kuzuya M; Imaizumi A; Arai H · The journal of nutrition, health & aging · 2021
    Cohort study427 participantsBrain Health forPhenylalanine
  12. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change.
    Cleary MA; Walter JH; Wraith JE; White F; Tyler K; Jenkins JP · The Journal of pediatrics · 1995
    Non-randomized trial41 participantsBrain Health forPhenylalanine
  13. [Cross-sectional association between the amino acid intake and episodic memory in middle- and old-aged community dwellers].
    Kinoshita K; Otsuka R; Takada M; Tsukamoto-Yasui M; Nishita Y; Tange C; Tomida M; Shimokata H; Imaizumi A; Arai H · Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics · 2021
    Cross-sectional study2,082 participantsBrain Health forPhenylalanine
  14. Improved dietary control results in improvements in indices of white matter structure in adults with phenylketonuria: the ReDAPT study.
    Kang MJY; Adamson C; Malpas CB; Winton-Brown T; Burgess N; Fazio T; Velakoulis D; Desmond P; Venkatraman V; De Jong G; Walterfang M · Acta neuropsychiatrica · 2026
    Single-arm trial7 participantsBrain Health forPhenylalanine
  15. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM · Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2006
    Single-arm trial19 participantsBrain Health forPhenylalanine
  16. Combined L-carnosine and L-tyrosine supplementation as an ergogenic strategy for physical and cognitive performance under fatigue in professional football players.
    Bilgin S; Bozyılan E; Buzdağlı Y; Karaç Öcal Y; Gürkan O; Toktaş S; İnan H; Egil İ; Yarayan YE · Frontiers in nutrition · 2026
    Randomized trial24 participantsBrain Health forTyrosine
  17. Influence of nutritional tyrosine on cognition and functional connectivity in healthy old humans.
    Hensel C; Becker M; Düzel S; Demuth I; Norman K; Steinhagen-Thiessen E; Gallinat J; Lindenberger U; Kühn S · NeuroImage · 2019
    Cross-sectional study286 participantsBrain Health forTyrosine
  18. Dietary Tyrosine Intake (FFQ) Is Associated with Locus Coeruleus, Attention and Grey Matter Maintenance: An MRI Structural Study on 398 Healthy Individuals of the Berlin Aging Study-II.
    Plini ERG; Melnychuk MC; Harkin A; Dahl MJ; McAuslan M; Kühn S; Boyle RT; Whelan R; Andrews R; Düzel S; Drewelies J; Wagner GG; Lindenberger U; Norman K; Robertson IH; Dockree PM · The journal of nutrition, health & aging · 2023
    Cross-sectional study398 participantsBrain Health forTyrosine